Review



proteome profiler human angiogenesis antibody array kit  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    R&D Systems proteome profiler human angiogenesis antibody array kit
    A) Representative image of the <t>Proteome</t> Profiler™ Human <t>Angiogenesis</t> Antibody Array in hCMEC/D3 treated (48 h) with mirVana™ miRNA Mimic, Negative Control (Scramble), or hsa-miR-9-5p (10 nM). Left image densitometry of the representative blots. Right images represent ImageJ conversion in arbitrary color scale (white to blue, representing low and high expression respectively). B) Log2 fold of change of differentially expressed proteins. Scatter line represent 0.5 Log fold of change. C) Protein-protein interaction (PPI) network construction and cluster analysis as described in methods section. D) VCAM-1 protein levels in cell culture supernatants of hCMEC/D3 after stimulation with tumor necrosis factor-α (TNF-α, of 10 ng/mL for 16 hours) in presence of hsa-miR-9-5p (10 nM). The control groups received an equivalent volume of fresh supplemented EGM-2 growth medium with and without scramble construct. VCAM-1: vascular cell adhesion molecule 1, NS, non-significant differences. ** p <0.01. *** p <0.001; **** p <0.0001.
    Proteome Profiler Human Angiogenesis Antibody Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 436 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteome profiler human angiogenesis antibody array kit/product/R&D Systems
    Average 96 stars, based on 436 article reviews
    proteome profiler human angiogenesis antibody array kit - by Bioz Stars, 2026-02
    96/100 stars

    Images

    1) Product Images from "hsa-miR-9-5p highly expressed in syncytiotrophoblast-derived extracellular vesicles from early-onset preeclampsia impairs cerebral microvascular endothelial cell pro-angiogenic capacity"

    Article Title: hsa-miR-9-5p highly expressed in syncytiotrophoblast-derived extracellular vesicles from early-onset preeclampsia impairs cerebral microvascular endothelial cell pro-angiogenic capacity

    Journal: bioRxiv

    doi: 10.1101/2024.10.21.619546

    A) Representative image of the Proteome Profiler™ Human Angiogenesis Antibody Array in hCMEC/D3 treated (48 h) with mirVana™ miRNA Mimic, Negative Control (Scramble), or hsa-miR-9-5p (10 nM). Left image densitometry of the representative blots. Right images represent ImageJ conversion in arbitrary color scale (white to blue, representing low and high expression respectively). B) Log2 fold of change of differentially expressed proteins. Scatter line represent 0.5 Log fold of change. C) Protein-protein interaction (PPI) network construction and cluster analysis as described in methods section. D) VCAM-1 protein levels in cell culture supernatants of hCMEC/D3 after stimulation with tumor necrosis factor-α (TNF-α, of 10 ng/mL for 16 hours) in presence of hsa-miR-9-5p (10 nM). The control groups received an equivalent volume of fresh supplemented EGM-2 growth medium with and without scramble construct. VCAM-1: vascular cell adhesion molecule 1, NS, non-significant differences. ** p <0.01. *** p <0.001; **** p <0.0001.
    Figure Legend Snippet: A) Representative image of the Proteome Profiler™ Human Angiogenesis Antibody Array in hCMEC/D3 treated (48 h) with mirVana™ miRNA Mimic, Negative Control (Scramble), or hsa-miR-9-5p (10 nM). Left image densitometry of the representative blots. Right images represent ImageJ conversion in arbitrary color scale (white to blue, representing low and high expression respectively). B) Log2 fold of change of differentially expressed proteins. Scatter line represent 0.5 Log fold of change. C) Protein-protein interaction (PPI) network construction and cluster analysis as described in methods section. D) VCAM-1 protein levels in cell culture supernatants of hCMEC/D3 after stimulation with tumor necrosis factor-α (TNF-α, of 10 ng/mL for 16 hours) in presence of hsa-miR-9-5p (10 nM). The control groups received an equivalent volume of fresh supplemented EGM-2 growth medium with and without scramble construct. VCAM-1: vascular cell adhesion molecule 1, NS, non-significant differences. ** p <0.01. *** p <0.001; **** p <0.0001.

    Techniques Used: Ab Array, Negative Control, Expressing, Cell Culture, Control, Construct



    Similar Products

    96
    R&D Systems proteome profiler human angiogenesis antibody array kit
    A) Representative image of the <t>Proteome</t> Profiler™ Human <t>Angiogenesis</t> Antibody Array in hCMEC/D3 treated (48 h) with mirVana™ miRNA Mimic, Negative Control (Scramble), or hsa-miR-9-5p (10 nM). Left image densitometry of the representative blots. Right images represent ImageJ conversion in arbitrary color scale (white to blue, representing low and high expression respectively). B) Log2 fold of change of differentially expressed proteins. Scatter line represent 0.5 Log fold of change. C) Protein-protein interaction (PPI) network construction and cluster analysis as described in methods section. D) VCAM-1 protein levels in cell culture supernatants of hCMEC/D3 after stimulation with tumor necrosis factor-α (TNF-α, of 10 ng/mL for 16 hours) in presence of hsa-miR-9-5p (10 nM). The control groups received an equivalent volume of fresh supplemented EGM-2 growth medium with and without scramble construct. VCAM-1: vascular cell adhesion molecule 1, NS, non-significant differences. ** p <0.01. *** p <0.001; **** p <0.0001.
    Proteome Profiler Human Angiogenesis Antibody Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteome profiler human angiogenesis antibody array kit/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    proteome profiler human angiogenesis antibody array kit - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    97
    Bio-Techne corporation proteome profiler human angiogenesis array kit
    A) Representative image of the <t>Proteome</t> Profiler™ Human <t>Angiogenesis</t> Antibody Array in hCMEC/D3 treated (48 h) with mirVana™ miRNA Mimic, Negative Control (Scramble), or hsa-miR-9-5p (10 nM). Left image densitometry of the representative blots. Right images represent ImageJ conversion in arbitrary color scale (white to blue, representing low and high expression respectively). B) Log2 fold of change of differentially expressed proteins. Scatter line represent 0.5 Log fold of change. C) Protein-protein interaction (PPI) network construction and cluster analysis as described in methods section. D) VCAM-1 protein levels in cell culture supernatants of hCMEC/D3 after stimulation with tumor necrosis factor-α (TNF-α, of 10 ng/mL for 16 hours) in presence of hsa-miR-9-5p (10 nM). The control groups received an equivalent volume of fresh supplemented EGM-2 growth medium with and without scramble construct. VCAM-1: vascular cell adhesion molecule 1, NS, non-significant differences. ** p <0.01. *** p <0.001; **** p <0.0001.
    Proteome Profiler Human Angiogenesis Array Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteome profiler human angiogenesis array kit/product/Bio-Techne corporation
    Average 97 stars, based on 1 article reviews
    proteome profiler human angiogenesis array kit - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    96
    R&D Systems antibody microarray
    A) Representative image of the <t>Proteome</t> Profiler™ Human <t>Angiogenesis</t> Antibody Array in hCMEC/D3 treated (48 h) with mirVana™ miRNA Mimic, Negative Control (Scramble), or hsa-miR-9-5p (10 nM). Left image densitometry of the representative blots. Right images represent ImageJ conversion in arbitrary color scale (white to blue, representing low and high expression respectively). B) Log2 fold of change of differentially expressed proteins. Scatter line represent 0.5 Log fold of change. C) Protein-protein interaction (PPI) network construction and cluster analysis as described in methods section. D) VCAM-1 protein levels in cell culture supernatants of hCMEC/D3 after stimulation with tumor necrosis factor-α (TNF-α, of 10 ng/mL for 16 hours) in presence of hsa-miR-9-5p (10 nM). The control groups received an equivalent volume of fresh supplemented EGM-2 growth medium with and without scramble construct. VCAM-1: vascular cell adhesion molecule 1, NS, non-significant differences. ** p <0.01. *** p <0.001; **** p <0.0001.
    Antibody Microarray, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody microarray/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    antibody microarray - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    97
    R&D Systems proteome profilertm human angiogenesis antibody array
    A) Representative image of the <t>Proteome</t> Profiler™ Human <t>Angiogenesis</t> Antibody Array in hCMEC/D3 treated (48 h) with mirVana™ miRNA Mimic, Negative Control (Scramble), or hsa-miR-9-5p (10 nM). Left image densitometry of the representative blots. Right images represent ImageJ conversion in arbitrary color scale (white to blue, representing low and high expression respectively). B) Log2 fold of change of differentially expressed proteins. Scatter line represent 0.5 Log fold of change. C) Protein-protein interaction (PPI) network construction and cluster analysis as described in methods section. D) VCAM-1 protein levels in cell culture supernatants of hCMEC/D3 after stimulation with tumor necrosis factor-α (TNF-α, of 10 ng/mL for 16 hours) in presence of hsa-miR-9-5p (10 nM). The control groups received an equivalent volume of fresh supplemented EGM-2 growth medium with and without scramble construct. VCAM-1: vascular cell adhesion molecule 1, NS, non-significant differences. ** p <0.01. *** p <0.001; **** p <0.0001.
    Proteome Profilertm Human Angiogenesis Antibody Array, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteome profilertm human angiogenesis antibody array/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    proteome profilertm human angiogenesis antibody array - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    R&D Systems proteome profiler human angiogenesis array kit
    A) Representative image of the <t>Proteome</t> Profiler™ Human <t>Angiogenesis</t> Antibody Array in hCMEC/D3 treated (48 h) with mirVana™ miRNA Mimic, Negative Control (Scramble), or hsa-miR-9-5p (10 nM). Left image densitometry of the representative blots. Right images represent ImageJ conversion in arbitrary color scale (white to blue, representing low and high expression respectively). B) Log2 fold of change of differentially expressed proteins. Scatter line represent 0.5 Log fold of change. C) Protein-protein interaction (PPI) network construction and cluster analysis as described in methods section. D) VCAM-1 protein levels in cell culture supernatants of hCMEC/D3 after stimulation with tumor necrosis factor-α (TNF-α, of 10 ng/mL for 16 hours) in presence of hsa-miR-9-5p (10 nM). The control groups received an equivalent volume of fresh supplemented EGM-2 growth medium with and without scramble construct. VCAM-1: vascular cell adhesion molecule 1, NS, non-significant differences. ** p <0.01. *** p <0.001; **** p <0.0001.
    Proteome Profiler Human Angiogenesis Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteome profiler human angiogenesis array kit/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    proteome profiler human angiogenesis array kit - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    R&D Systems proteome profiler human angiogenesis antibody array
    B55α depletion affects TSP1 in endothelial cells. ( A ) Cell lysates of non-targeting siRNA and B55α-specific siRNA (siPPP2R2A)-treated BPAEC were incubated on angiogenetic-specific antibodies containing <t>proteome</t> profiler array membrane. Quantification of the dots was performed using the ImageJ software (version 1.54h). Bars represent the mean of duplicated dots ± SD. Statistical analysis was performed by unpaired t-test (* p < 0.05, ** p < 0.01, and *** p < 0.001). ( B ) Control, non-targeting, and B55α-specific siRNA-treated BPAEC lysates were tested by Western blot. Quantitative analysis was performed by densitometry of the blots using actin bands for normalization. Statistical analysis was performed using ANOVA Tukey’s test (n = 3, *** p < 0.001). ( C ) qPCR measurements were made using mRNA from nonsiRNA and B55α-depleted (siPPP2R2A) BPAEC cells. Quantitative analysis of B55α and TSP1 signals are shown. GAPDH was used for mRNA-level normalization. Significant differences were determined by unpaired t-test (n = 3, *** p < 0.001).
    Proteome Profiler Human Angiogenesis Antibody Array, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proteome profiler human angiogenesis antibody array/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    proteome profiler human angiogenesis antibody array - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    86
    Danaher Inc human angiogenesis antibody array kit
    B55α depletion affects TSP1 in endothelial cells. ( A ) Cell lysates of non-targeting siRNA and B55α-specific siRNA (siPPP2R2A)-treated BPAEC were incubated on angiogenetic-specific antibodies containing <t>proteome</t> profiler array membrane. Quantification of the dots was performed using the ImageJ software (version 1.54h). Bars represent the mean of duplicated dots ± SD. Statistical analysis was performed by unpaired t-test (* p < 0.05, ** p < 0.01, and *** p < 0.001). ( B ) Control, non-targeting, and B55α-specific siRNA-treated BPAEC lysates were tested by Western blot. Quantitative analysis was performed by densitometry of the blots using actin bands for normalization. Statistical analysis was performed using ANOVA Tukey’s test (n = 3, *** p < 0.001). ( C ) qPCR measurements were made using mRNA from nonsiRNA and B55α-depleted (siPPP2R2A) BPAEC cells. Quantitative analysis of B55α and TSP1 signals are shown. GAPDH was used for mRNA-level normalization. Significant differences were determined by unpaired t-test (n = 3, *** p < 0.001).
    Human Angiogenesis Antibody Array Kit, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human angiogenesis antibody array kit/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    human angiogenesis antibody array kit - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    97
    R&D Systems angiogenic factor antibody microarray
    B55α depletion affects TSP1 in endothelial cells. ( A ) Cell lysates of non-targeting siRNA and B55α-specific siRNA (siPPP2R2A)-treated BPAEC were incubated on angiogenetic-specific antibodies containing <t>proteome</t> profiler array membrane. Quantification of the dots was performed using the ImageJ software (version 1.54h). Bars represent the mean of duplicated dots ± SD. Statistical analysis was performed by unpaired t-test (* p < 0.05, ** p < 0.01, and *** p < 0.001). ( B ) Control, non-targeting, and B55α-specific siRNA-treated BPAEC lysates were tested by Western blot. Quantitative analysis was performed by densitometry of the blots using actin bands for normalization. Statistical analysis was performed using ANOVA Tukey’s test (n = 3, *** p < 0.001). ( C ) qPCR measurements were made using mRNA from nonsiRNA and B55α-depleted (siPPP2R2A) BPAEC cells. Quantitative analysis of B55α and TSP1 signals are shown. GAPDH was used for mRNA-level normalization. Significant differences were determined by unpaired t-test (n = 3, *** p < 0.001).
    Angiogenic Factor Antibody Microarray, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/angiogenic factor antibody microarray/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    angiogenic factor antibody microarray - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    97
    R&D Systems antibody arrays
    B55α depletion affects TSP1 in endothelial cells. ( A ) Cell lysates of non-targeting siRNA and B55α-specific siRNA (siPPP2R2A)-treated BPAEC were incubated on angiogenetic-specific antibodies containing <t>proteome</t> profiler array membrane. Quantification of the dots was performed using the ImageJ software (version 1.54h). Bars represent the mean of duplicated dots ± SD. Statistical analysis was performed by unpaired t-test (* p < 0.05, ** p < 0.01, and *** p < 0.001). ( B ) Control, non-targeting, and B55α-specific siRNA-treated BPAEC lysates were tested by Western blot. Quantitative analysis was performed by densitometry of the blots using actin bands for normalization. Statistical analysis was performed using ANOVA Tukey’s test (n = 3, *** p < 0.001). ( C ) qPCR measurements were made using mRNA from nonsiRNA and B55α-depleted (siPPP2R2A) BPAEC cells. Quantitative analysis of B55α and TSP1 signals are shown. GAPDH was used for mRNA-level normalization. Significant differences were determined by unpaired t-test (n = 3, *** p < 0.001).
    Antibody Arrays, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody arrays/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    antibody arrays - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    Image Search Results


    A) Representative image of the Proteome Profiler™ Human Angiogenesis Antibody Array in hCMEC/D3 treated (48 h) with mirVana™ miRNA Mimic, Negative Control (Scramble), or hsa-miR-9-5p (10 nM). Left image densitometry of the representative blots. Right images represent ImageJ conversion in arbitrary color scale (white to blue, representing low and high expression respectively). B) Log2 fold of change of differentially expressed proteins. Scatter line represent 0.5 Log fold of change. C) Protein-protein interaction (PPI) network construction and cluster analysis as described in methods section. D) VCAM-1 protein levels in cell culture supernatants of hCMEC/D3 after stimulation with tumor necrosis factor-α (TNF-α, of 10 ng/mL for 16 hours) in presence of hsa-miR-9-5p (10 nM). The control groups received an equivalent volume of fresh supplemented EGM-2 growth medium with and without scramble construct. VCAM-1: vascular cell adhesion molecule 1, NS, non-significant differences. ** p <0.01. *** p <0.001; **** p <0.0001.

    Journal: bioRxiv

    Article Title: hsa-miR-9-5p highly expressed in syncytiotrophoblast-derived extracellular vesicles from early-onset preeclampsia impairs cerebral microvascular endothelial cell pro-angiogenic capacity

    doi: 10.1101/2024.10.21.619546

    Figure Lengend Snippet: A) Representative image of the Proteome Profiler™ Human Angiogenesis Antibody Array in hCMEC/D3 treated (48 h) with mirVana™ miRNA Mimic, Negative Control (Scramble), or hsa-miR-9-5p (10 nM). Left image densitometry of the representative blots. Right images represent ImageJ conversion in arbitrary color scale (white to blue, representing low and high expression respectively). B) Log2 fold of change of differentially expressed proteins. Scatter line represent 0.5 Log fold of change. C) Protein-protein interaction (PPI) network construction and cluster analysis as described in methods section. D) VCAM-1 protein levels in cell culture supernatants of hCMEC/D3 after stimulation with tumor necrosis factor-α (TNF-α, of 10 ng/mL for 16 hours) in presence of hsa-miR-9-5p (10 nM). The control groups received an equivalent volume of fresh supplemented EGM-2 growth medium with and without scramble construct. VCAM-1: vascular cell adhesion molecule 1, NS, non-significant differences. ** p <0.01. *** p <0.001; **** p <0.0001.

    Article Snippet: The expression patterns of proteins associated with angiogenesis were assessed utilizing the Proteome Profiler™ Human Angiogenesis Antibody Array Kit (R&D Systems, Minneapolis, MN, USA).

    Techniques: Ab Array, Negative Control, Expressing, Cell Culture, Control, Construct

    B55α depletion affects TSP1 in endothelial cells. ( A ) Cell lysates of non-targeting siRNA and B55α-specific siRNA (siPPP2R2A)-treated BPAEC were incubated on angiogenetic-specific antibodies containing proteome profiler array membrane. Quantification of the dots was performed using the ImageJ software (version 1.54h). Bars represent the mean of duplicated dots ± SD. Statistical analysis was performed by unpaired t-test (* p < 0.05, ** p < 0.01, and *** p < 0.001). ( B ) Control, non-targeting, and B55α-specific siRNA-treated BPAEC lysates were tested by Western blot. Quantitative analysis was performed by densitometry of the blots using actin bands for normalization. Statistical analysis was performed using ANOVA Tukey’s test (n = 3, *** p < 0.001). ( C ) qPCR measurements were made using mRNA from nonsiRNA and B55α-depleted (siPPP2R2A) BPAEC cells. Quantitative analysis of B55α and TSP1 signals are shown. GAPDH was used for mRNA-level normalization. Significant differences were determined by unpaired t-test (n = 3, *** p < 0.001).

    Journal: International Journal of Molecular Sciences

    Article Title: PP2A Affects Angiogenesis via Its Interaction with a Novel Phosphorylation Site of TSP1

    doi: 10.3390/ijms25031844

    Figure Lengend Snippet: B55α depletion affects TSP1 in endothelial cells. ( A ) Cell lysates of non-targeting siRNA and B55α-specific siRNA (siPPP2R2A)-treated BPAEC were incubated on angiogenetic-specific antibodies containing proteome profiler array membrane. Quantification of the dots was performed using the ImageJ software (version 1.54h). Bars represent the mean of duplicated dots ± SD. Statistical analysis was performed by unpaired t-test (* p < 0.05, ** p < 0.01, and *** p < 0.001). ( B ) Control, non-targeting, and B55α-specific siRNA-treated BPAEC lysates were tested by Western blot. Quantitative analysis was performed by densitometry of the blots using actin bands for normalization. Statistical analysis was performed using ANOVA Tukey’s test (n = 3, *** p < 0.001). ( C ) qPCR measurements were made using mRNA from nonsiRNA and B55α-depleted (siPPP2R2A) BPAEC cells. Quantitative analysis of B55α and TSP1 signals are shown. GAPDH was used for mRNA-level normalization. Significant differences were determined by unpaired t-test (n = 3, *** p < 0.001).

    Article Snippet: Proteome Profiler Human Angiogenesis Antibody Array (ARY007) was ordered from R&D Systems, Inc. (Minneapolis, MN, USA).

    Techniques: Incubation, Membrane, Software, Control, Western Blot